TSTO Product Line (Tetrasilver Tetroxide Formulations)

The TSTO product line is the set of commercial formulations built around Tetrasilver Tetroxide (Ag₄O₄) (Ag₄O₄) and marketed by its originator, Marvin S. Antelman. The product/sales page captured in [source note 1] is the wiki's clearest record of the line as a commercial offering rather than as a patent disclosure.

What the line is

The page presents TSTO as a multi-purpose antimicrobial agent sold in several formulations. The applications named in the capture center on:

• Topical wound and skin care — SilverQuine Animal Wound Dressing for minor cuts, lacerations, abrasions, first- and second-degree burns, and skin irritations.
• Topical antimicrobial skin ointments — Tetrasil/Terrasil and Genisil, marketed for viral, bacterial, and fungal skin conditions.
• Broad-spectrum antimicrobial action — asserted against bacteria, viruses, and fungi.

The capture also reproduces an FDA warning letter concerning the marketing of Tetrasil and Genisil.

Claimed basis

The formulations are said to work through a micro-electrical charge and therapeutic-oxygen release that kills pathogens on contact, together with a redox reaction and chelation of silver around viral surfaces. This framing is attributed in the source to the vendor and to Dr. Horowitz. The general antimicrobial action of silver, the Antimicrobial Silver and the Oligodynamic Effect, is a separate and well-documented phenomenon; the product line's specific mechanism and efficacy claims are not corroborated by the capture.

Evidence status

The capture offers product marketing copy, references to patents, and an FDA warning letter stating that Tetrasil and Genisil are unapproved new drugs and that adequate data are lacking to establish general recognition of the safety and effectiveness of silver salts for OTC use. It contains no clinical trials, no independent replication, and no quantitative efficacy data — no concentrations, contact times, or kill-rate figures. Under the wiki's Patent as Evidence convention, patent references document claims rather than establish that the claimed effects occur. The cross-capture assessment lives at Tetrasilver Tetroxide: The Electron-Jumping Claim, the Patent Set and the Bounded Evidence.

Open question

Whether this product page names formulations or product designations not already present in the three prior TSTO captures remains unresolved. If it does not, the line is best treated as a single commercial offering documented across several near-duplicate captures rather than as a family of distinct products.

Related

• Tetrasilver Tetroxide (Ag₄O₄) — the active material.
• Marvin S. Antelman — the originator.
• Water Disinfection by Silver — the primary claimed application.
• Tetrasilver Tetroxide: The Electron-Jumping Claim, the Patent Set and the Bounded Evidence — the evidence assessment.